Palatin Technologies (PTN) Stock Analysis & AI Equity Report

Medical - Pharmaceuticals USD Explore free reports

Palatin Technologies (PTN) overview

Palatin Technologies (PTN) stock analysis and AI equity research. For financial year 2026, Valuatum's model shows revenue of USD 13.2m and operating profit of USD -8.7m; the year-end share price was 10.79 USD and market capitalisation was USD 19.2m. Palatin Technologies is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Palatin Technologies's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 6.7mFY 2026
Share price10.79 USDFY 2026 year end
RevenueUSD 13.2mFY 2026
Operating profitUSD -8.7mFY 2026
Net earningsUSD -8.4mFY 2026
Market capitalisationUSD 19.2mFY 2026 year end

About Palatin Technologies

Palatin Technologies develops peptide and small-molecule medicines that modulate melanocortin receptors. Its principal internal focus is selective MC4R agonists for rare obesity disorders associated with the MC4R pathway, including hypothalamic obesity, Prader-Willi syndrome and Bardet-Biedl syndrome. Programs include peptide candidates and oral small molecules progressing through preclinical development. Palatin also partners or licenses other receptor-based programs, including work in retinal disease.

Generate the Palatin Technologies report

Palatin Technologies is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Palatin Technologies and represent financial year 2026. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Palatin Technologies

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.